Redeye: Tessin - Capital still a limitation of growth
Redeye updates its estimates and valuation after reviewing Tessin's Q1 report, which showed lower sales and profitability than expected. All eyes continue to be on securing institutional capital, and until then, we expect muted loan volumes in the coming quarters.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/